Li AJ, Karlan BY. Surgical advances in the treatment of ovarian cancer. Hematol Oncol Clin North Am 2003;17:945–956.
84.
Ben David Y, Chetrit A, Hirsh-Yechezkel G, et al. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 2002;20:463–466.
85.
Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer 1985;56:2727–2732.
86.
Goff BA, Mandel LS, Muntz HG, et al. Ovarian cancer diagnosis: results of a national ovarian cancer survey. Cancer 2000;89:2068– 2075.
87.
Olson SSH, Mignone L, Nakraseive C, et al. Symptoms of ovarian cancer. Obstet Gynecol 2001;98:212–217.
88.
Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007;109:221–227.
89.
Olsen CM, Cnossen J, Green AC, et al. Comparison of symptoms and presentation of women with benign, low malignant potential and invasive ovarian tumors. Eur J Gynaecol Oncol 2007;28:376– 380.
90.
Hogg R, Friedlander M. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J Clin Oncol 2004;22:1315–1327.
91.
Barber HK, Grober EA. The PMPO syndrome (postmenopausal palpable ovary syndrome). Obstet Gynecol 1971;138:921–923.
92.
Malkasian GD, Knapp RC, Lavin PT, et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341–346.
93.
Campbell S, Royston P, Bhan V, et al. Novel screening strategies for early ovarian cancer by transabdominal ultrasonography. BJOG 1990;97:304–311.
94.
van Nagell JR Jr, Higgins RV, Donaldson ES, et al. Transvaginal sonography as a screening method for ovarian cancer: a report of the first 1000 cases screened. Cancer 1990;65:573–577.
95.
van Nagell JR Jr, Gallion HH, Pavlik EJ, et al. Ovarian cancer screening. Cancer 1995;76:2086–2091.
96.
van Nagell JR Jr, DePriest PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000;77:350–356.
97.
Ueland FR, DePriest PD, Pavlik EJ, et al. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler ﬂow sonography. Gynecol Oncol 2003;91:46–50.
98.